As of 2026-03-20, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -2.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 1,266.46 mil USD. VIR's TTM EBITDA according to its financial statements is -468.24 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 13.0x | 10.4x |
| Forward P/E multiples | 7.9x - 12.7x | 9.4x |
| Fair Price | (25.10) - (35.71) | (27.56) |
| Upside | -367.6% - -480.7% | -393.8% |
| Date | EV/EBITDA |
| 2026-03-13 | -2.66 |
| 2026-03-12 | -2.74 |
| 2026-03-11 | -2.85 |
| 2026-03-10 | -2.88 |
| 2026-03-09 | -2.85 |
| 2026-03-06 | -2.76 |
| 2026-03-05 | -2.61 |
| 2026-03-04 | -2.77 |
| 2026-03-03 | -2.54 |
| 2026-03-02 | -2.69 |
| 2026-02-27 | -2.61 |
| 2026-02-26 | -2.68 |
| 2026-02-25 | -2.92 |
| 2026-02-24 | -2.74 |
| 2026-02-23 | -2.04 |
| 2026-02-20 | -2.08 |
| 2026-02-19 | -2.17 |
| 2026-02-18 | -2.18 |
| 2026-02-17 | -2.06 |
| 2026-02-13 | -2.05 |
| 2026-02-12 | -2.13 |
| 2026-02-11 | -2.04 |
| 2026-02-10 | -2.07 |
| 2026-02-09 | -1.99 |
| 2026-02-06 | -1.96 |
| 2026-02-05 | -1.87 |
| 2026-02-04 | -2.06 |
| 2026-02-03 | -2.12 |
| 2026-02-02 | -2.13 |
| 2026-01-30 | -2.04 |
| 2026-01-29 | -2.16 |
| 2026-01-28 | -2.09 |
| 2026-01-27 | -2.13 |
| 2026-01-26 | -2.05 |
| 2026-01-23 | -2.08 |
| 2026-01-22 | -2.03 |
| 2026-01-21 | -1.87 |
| 2026-01-20 | -1.55 |
| 2026-01-16 | -1.57 |
| 2026-01-15 | -1.62 |
| 2026-01-14 | -1.83 |
| 2026-01-13 | -1.66 |
| 2026-01-12 | -1.52 |
| 2026-01-09 | -1.50 |
| 2026-01-08 | -1.53 |
| 2026-01-07 | -1.61 |
| 2026-01-06 | -1.54 |
| 2026-01-05 | -1.48 |
| 2026-01-02 | -1.53 |
| 2025-12-31 | -1.56 |